Norepinephrine/Vanylglycol ratio
|
Basic information |
| Metabolite name | Norepinephrine/Vanylglycol ratio |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | NA |
| No. of studies | 1 |
|
Basic information |
| Metabolite name | Norepinephrine/Vanylglycol ratio |
| N/A |
|
N/A |
|
N/A |
| Synonyms | NA |
| No. of studies | 1 |
|
Relationship between Norepinephrine/Vanylglycol ratio and depression (count: 1) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M922 | Type1 | CUMS group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M922 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M922 | Type2 | CUMS + middle dose of P. orientalis group vs. CUMS group | Prefrontal cortex | Sprague-Dawley rat | Up |
| Study M922 | Type2 | CUMS + high dose of P. orientalis group vs. CUMS group | Prefrontal cortex | Sprague-Dawley rat | Up |
| Study M922 | Type2 | CUMS + high dose of P. orientalis group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |